Chronix Biomedical Adds State-of-the-art Mass Seqeuncing Capabilities to Accelerate Development of it's DNA Biomakers for Early Detection of Cancer | Biomarker Commons

Chronix Biomedical Adds State-of-the-art Mass Seqeuncing Capabilities to Accelerate Development of it's DNA Biomakers for Early Detection of Cancer